Cargando…
Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial
BACKGROUND: After a stroke, 80% of the chronic patients have difficulties to use their paretic upper limb (UL) in activities of daily life (ADL) even after rehabilitation. Virtual reality therapy (VRT) and anodal transcranial direct current stimulation (tDCS) are two innovative methods that have sho...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549202/ https://www.ncbi.nlm.nih.gov/pubmed/34702317 http://dx.doi.org/10.1186/s13063-021-05689-5 |
_version_ | 1784590736101998592 |
---|---|
author | Muller, Camille O. Muthalib, Makii Mottet, Denis Perrey, Stéphane Dray, Gérard Delorme, Marion Duflos, Claire Froger, Jérôme Xu, Binbin Faity, Germain Pla, Simon Jean, Pierre Laffont, Isabelle Bakhti, Karima K. A. |
author_facet | Muller, Camille O. Muthalib, Makii Mottet, Denis Perrey, Stéphane Dray, Gérard Delorme, Marion Duflos, Claire Froger, Jérôme Xu, Binbin Faity, Germain Pla, Simon Jean, Pierre Laffont, Isabelle Bakhti, Karima K. A. |
author_sort | Muller, Camille O. |
collection | PubMed |
description | BACKGROUND: After a stroke, 80% of the chronic patients have difficulties to use their paretic upper limb (UL) in activities of daily life (ADL) even after rehabilitation. Virtual reality therapy (VRT) and anodal transcranial direct current stimulation (tDCS) are two innovative methods that have shown independently to positively impact functional recovery of the paretic UL when combined with conventional therapy. The objective of the project will be to evaluate the impact of adding anodal high-definition (HD)-tDCS during an intensive 3-week UL VRT and conventional therapy program on paretic UL function in chronic stroke. METHODS: The ReArm project is a quadruple-blinded, randomized, sham-controlled, bi-centre, two-arm parallel, and interventional study design. Fifty-eight chronic (> 3 months) stroke patients will be recruited from the Montpellier and Nimes University Hospitals. Patients will follow a standard 3-week in-patient rehabilitation program, which includes 13 days of VRT (Armeo Spring, 1 × 30 min session/day) and conventional therapy (3 × 30 min sessions/day). Twenty-nine patients will receive real stimulation (4x1 anodal HD-tDCS montage, 2 mA, 20 min) to the ipsilesional primary motor cortex during the VRT session and the other 29 patients will receive active sham stimulation (2 mA, 30 s). All outcome measures will be assessed at baseline, at the end of rehabilitation and again 3 months later. The primary outcome measure will be the wolf motor function test. Secondary outcomes will include measures of UL function (Box and Block Test), impairment (Fugl Meyer Upper Extremity), compensation (Proximal Arm Non-Use), ADL (Actimetry, Barthel Index). Other/exploratory outcomes will include pain, fatigue, effort and performance, kinematics, and motor cortical region activation during functional motor tasks. DISCUSSION: This will be the first trial to determine the impact of adding HD-tDCS during UL VRT and conventional therapy in chronic stroke patients. We hypothesize that improvements in UL function will be greater and longer-lasting with real stimulation than in those receiving sham. TRIAL REGISTRATION: The ReArm project was approved by The French Research Ethics Committee, (Comité de Protection des Personnes-CPP SUD-EST II, N°ID-RCB: 2019-A00506-51, http://www.cppsudest2.fr/). The ReArm project was registered on ClinicalTrials.gov (NCT04291573, 2(nd) March 2020. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05689-5. |
format | Online Article Text |
id | pubmed-8549202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85492022021-10-27 Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial Muller, Camille O. Muthalib, Makii Mottet, Denis Perrey, Stéphane Dray, Gérard Delorme, Marion Duflos, Claire Froger, Jérôme Xu, Binbin Faity, Germain Pla, Simon Jean, Pierre Laffont, Isabelle Bakhti, Karima K. A. Trials Study Protocol BACKGROUND: After a stroke, 80% of the chronic patients have difficulties to use their paretic upper limb (UL) in activities of daily life (ADL) even after rehabilitation. Virtual reality therapy (VRT) and anodal transcranial direct current stimulation (tDCS) are two innovative methods that have shown independently to positively impact functional recovery of the paretic UL when combined with conventional therapy. The objective of the project will be to evaluate the impact of adding anodal high-definition (HD)-tDCS during an intensive 3-week UL VRT and conventional therapy program on paretic UL function in chronic stroke. METHODS: The ReArm project is a quadruple-blinded, randomized, sham-controlled, bi-centre, two-arm parallel, and interventional study design. Fifty-eight chronic (> 3 months) stroke patients will be recruited from the Montpellier and Nimes University Hospitals. Patients will follow a standard 3-week in-patient rehabilitation program, which includes 13 days of VRT (Armeo Spring, 1 × 30 min session/day) and conventional therapy (3 × 30 min sessions/day). Twenty-nine patients will receive real stimulation (4x1 anodal HD-tDCS montage, 2 mA, 20 min) to the ipsilesional primary motor cortex during the VRT session and the other 29 patients will receive active sham stimulation (2 mA, 30 s). All outcome measures will be assessed at baseline, at the end of rehabilitation and again 3 months later. The primary outcome measure will be the wolf motor function test. Secondary outcomes will include measures of UL function (Box and Block Test), impairment (Fugl Meyer Upper Extremity), compensation (Proximal Arm Non-Use), ADL (Actimetry, Barthel Index). Other/exploratory outcomes will include pain, fatigue, effort and performance, kinematics, and motor cortical region activation during functional motor tasks. DISCUSSION: This will be the first trial to determine the impact of adding HD-tDCS during UL VRT and conventional therapy in chronic stroke patients. We hypothesize that improvements in UL function will be greater and longer-lasting with real stimulation than in those receiving sham. TRIAL REGISTRATION: The ReArm project was approved by The French Research Ethics Committee, (Comité de Protection des Personnes-CPP SUD-EST II, N°ID-RCB: 2019-A00506-51, http://www.cppsudest2.fr/). The ReArm project was registered on ClinicalTrials.gov (NCT04291573, 2(nd) March 2020. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05689-5. BioMed Central 2021-10-26 /pmc/articles/PMC8549202/ /pubmed/34702317 http://dx.doi.org/10.1186/s13063-021-05689-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Muller, Camille O. Muthalib, Makii Mottet, Denis Perrey, Stéphane Dray, Gérard Delorme, Marion Duflos, Claire Froger, Jérôme Xu, Binbin Faity, Germain Pla, Simon Jean, Pierre Laffont, Isabelle Bakhti, Karima K. A. Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial |
title | Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial |
title_full | Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial |
title_fullStr | Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial |
title_full_unstemmed | Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial |
title_short | Recovering arm function in chronic stroke patients using combined anodal HD-tDCS and virtual reality therapy (ReArm): a study protocol for a randomized controlled trial |
title_sort | recovering arm function in chronic stroke patients using combined anodal hd-tdcs and virtual reality therapy (rearm): a study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549202/ https://www.ncbi.nlm.nih.gov/pubmed/34702317 http://dx.doi.org/10.1186/s13063-021-05689-5 |
work_keys_str_mv | AT mullercamilleo recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT muthalibmakii recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT mottetdenis recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT perreystephane recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT draygerard recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT delormemarion recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT duflosclaire recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT frogerjerome recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT xubinbin recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT faitygermain recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT plasimon recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT jeanpierre recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT laffontisabelle recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial AT bakhtikarimaka recoveringarmfunctioninchronicstrokepatientsusingcombinedanodalhdtdcsandvirtualrealitytherapyrearmastudyprotocolforarandomizedcontrolledtrial |